Ongoing trial shows Pfizer Covid-19 vaccine remains highly effective after six months
The ongoing Phase 3 clinical trial of Pfizer/BioNTech’s coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday. The question …
